Advanced search
1 file | 501.93 KB Add to list

Quality-by-design risk assessment of topical formulation variability

Author
Organization
Keywords
Cyclic depsipeptide mycotoxins, Fusafungine, Enniatins, Excipient variability, Quality-by-Design (QbD), Transmucosal Franz diffusion cell, Plasma concentration after buccal application

Downloads

  • 2015 189b Poster 26th PBA Tbilisi Georgia Lien Taevernier.pdf
    • full text
    • |
    • open access
    • |
    • PDF
    • |
    • 501.93 KB

Citation

Please use this url to cite or link to this publication:

MLA
Taevernier, Lien, et al. “Quality-by-Design Risk Assessment of Topical Formulation Variability.” Pharmaceutical and Biomedical Analysis, 26th International Symposium, Abstracts, 2015.
APA
Taevernier, L., Detroyer, S., Veryser, L., & De Spiegeleer, B. (2015). Quality-by-design risk assessment of topical formulation variability. Pharmaceutical and Biomedical Analysis, 26th International Symposium, Abstracts. Presented at the 26th International symposium on Pharmaceutical and Biomedical Analysis (PBA 2015), Tbilisi, Georgia.
Chicago author-date
Taevernier, Lien, Sven Detroyer, Lieselotte Veryser, and Bart De Spiegeleer. 2015. “Quality-by-Design Risk Assessment of Topical Formulation Variability.” In Pharmaceutical and Biomedical Analysis, 26th International Symposium, Abstracts.
Chicago author-date (all authors)
Taevernier, Lien, Sven Detroyer, Lieselotte Veryser, and Bart De Spiegeleer. 2015. “Quality-by-Design Risk Assessment of Topical Formulation Variability.” In Pharmaceutical and Biomedical Analysis, 26th International Symposium, Abstracts.
Vancouver
1.
Taevernier L, Detroyer S, Veryser L, De Spiegeleer B. Quality-by-design risk assessment of topical formulation variability. In: Pharmaceutical and Biomedical Analysis, 26th International symposium, Abstracts. 2015.
IEEE
[1]
L. Taevernier, S. Detroyer, L. Veryser, and B. De Spiegeleer, “Quality-by-design risk assessment of topical formulation variability,” in Pharmaceutical and Biomedical Analysis, 26th International symposium, Abstracts, Tbilisi, Georgia, 2015.
@inproceedings{6855247,
  author       = {{Taevernier, Lien and Detroyer, Sven and Veryser, Lieselotte and De Spiegeleer, Bart}},
  booktitle    = {{Pharmaceutical and Biomedical Analysis, 26th International symposium, Abstracts}},
  keywords     = {{Cyclic depsipeptide mycotoxins,Fusafungine,Enniatins,Excipient variability,Quality-by-Design (QbD),Transmucosal Franz diffusion cell,Plasma concentration after buccal application}},
  language     = {{eng}},
  location     = {{Tbilisi, Georgia}},
  title        = {{Quality-by-design risk assessment of topical formulation variability}},
  year         = {{2015}},
}